- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/38 - StomachIntestineGoblet cellsOral mucosaSaliva
Patent holdings for IPC class A61K 35/38
Total number of patents in this class: 393
10-year publication summary
|
47
|
33
|
39
|
33
|
31
|
37
|
29
|
17
|
32
|
13
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ferring Microbiome Inc. | 41 |
26 |
| Elutia Med LLC | 39 |
22 |
| Elutia Inc. | 34 |
20 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3143 |
16 |
| Crestovo Holdings LLC | 19 |
12 |
| RegenLab USA LLC | 73 |
11 |
| Corvivo Cardiovascular, Inc. | 91 |
11 |
| Cook Biotech Incorporated | 208 |
10 |
| AlloSource | 153 |
7 |
| Yeda Research and Development Co. Ltd. | 1339 |
7 |
| Emanate Biomedical Inc. | 30 |
7 |
| ACell, Inc. | 71 |
6 |
| InCube Labs, LLC | 183 |
5 |
| Korea Research Institute of Bioscience and Biotechnology | 1061 |
5 |
| Minovia Therapeutics Ltd. | 52 |
5 |
| Ramot at Tel-Aviv University Ltd. | 1473 |
5 |
| Regents of the University of Minnesota | 2690 |
5 |
| Finch Therapeutics Holdings, LLC | 74 |
5 |
| Scarcell Therapeutics | 12 |
4 |
| Maat Pharma | 67 |
4 |
| Other owners | 200 |